NCT04171843 2023-09-21A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple MyelomaPrecision BioSciences, Inc.Phase 1 Terminated48 enrolled